Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CARD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NFYC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC01013 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC33A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA6-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBOAT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF3IP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on